1. Home
  2. KRMD vs STTK Comparison

KRMD vs STTK Comparison

Compare KRMD & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORU Medical Systems Inc. (DE)

KRMD

KORU Medical Systems Inc. (DE)

HOLD

Current Price

$5.61

Market Cap

272.8M

Sector

Health Care

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$4.09

Market Cap

275.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRMD
STTK
Founded
1980
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
272.8M
275.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
KRMD
STTK
Price
$5.61
$4.09
Analyst Decision
Strong Buy
Buy
Analyst Count
3
6
Target Price
$6.00
$4.00
AVG Volume (30 Days)
143.9K
887.9K
Earning Date
03-11-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$39,070,637.00
$1,000,000.00
Revenue This Year
$23.97
N/A
Revenue Next Year
$18.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.12
N/A
52 Week Low
$1.86
$0.69
52 Week High
$6.61
$4.89

Technical Indicators

Market Signals
Indicator
KRMD
STTK
Relative Strength Index (RSI) 49.03 52.66
Support Level $5.56 $4.10
Resistance Level $5.85 $4.65
Average True Range (ATR) 0.30 0.41
MACD -0.04 -0.10
Stochastic Oscillator 59.04 17.82

Price Performance

Historical Comparison
KRMD
STTK

About KRMD KORU Medical Systems Inc. (DE)

KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: